GeneOne Life Science

GeneOne Life Science, Inc. is a biopharmaceutical company that researches and develops DNA vaccines and plasmid-based biologics in South Korea and internationally. Its products include VGX-3400, a DNA vaccine in Phase I clinical trials for influenza, and VGX-6150, a therapeutic DNA vaccine undergoing Phase I clinical trials for hepatitis C.